跳至主要内容
临床试验/JPRN-UMIN000007698
JPRN-UMIN000007698已完成未知

An exploratory open trial to examine the safety of transplantation of autologous adipose tissue-derived stem cells for periodontal regeneration. - An exploratory open trial of transplantation of adipose tissue-derived stem cells for periodontal regeneration.

Osaka University0 个研究点目标入组 12 人开始时间: 2012年4月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

The autologous adipose tissue-derived stem cells(ADSC) were transplanted of into 12 patients, and the safety and effectiveness of periodontal regeneration by ADSC transplantation are currently being examined.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Persons whose clinical attachment level of experimental teeth cannot be measured. (2) Persons who have or have had malignant tumor. (3) Persons who are suspected to have malignant tumor or precancerous lesions at the oral cavity inspection before the registration. (4) Persons who have administered bisphosphonates, or are to administer the drug after the registration. (5) Persons who need to undergo the treatments, such as surgical treatment, restorative treatment or root canal treatment, which affect the experimental sites within 36 weeks after the transplantation of adipose tissue-derived stem cells. (6) Persons who are either pregnant, breast-feeding or possibly pregnant by the pregnancy test before the registration, or who hope to become pregnant within 36 weeks after the transplantation of adipose tissue-derived stem cells. (7) Persons who suffer from disorders of kidney, liver or blood. (8) Persons whose hemoglobinA1c is more than 6.5% in the blood test before the entry (9) Persons who suffer from active infectious diseases. (10) Persons who have the history of dependence on alcohol or drugs within 6 months before the registrarion. (11) Persons who suffer from mental or consciousness disorders. (12) Persons who have the positive reaction to the tests for hepatitis C virus antibody, hepatitis B virus antigen, human T-lymphotropic virus-1 antibody or human immunodeficiency virus antibody. (13) Persons who are judged not eligible for the subjects of this study by the principal investigator.

研究者

相似试验

An exploratory open trial to examine the safety of... | 临床试验